92993-58-3 Usage
Uses
Used in Research and Development:
1-Tosylazetidine-3-carboxylic acid is used as a research compound for its potential applications in organic synthesis, chemical biology, and materials science. Its unique structure and properties make it a valuable tool for exploring new chemical reactions and developing novel materials.
Used in Organic Synthesis:
1-Tosylazetidine-3-carboxylic acid is used as a synthetic intermediate for the preparation of various complex organic molecules. Its reactivity and functional groups allow for the construction of diverse chemical structures, making it a versatile building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Chemical Biology:
1-Tosylazetidine-3-carboxylic acid is used as a molecular probe in chemical biology to study the interactions between small molecules and biological targets. Its unique structure can be used to modulate the activity of enzymes, receptors, or other biomolecules, providing insights into their function and potential therapeutic applications.
Used in Materials Science:
1-Tosylazetidine-3-carboxylic acid is used as a component in the development of new materials with specific properties, such as polymers, coatings, or catalysts. Its chemical versatility allows for the tuning of material properties, making it a valuable asset in the design and synthesis of advanced materials for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 92993-58-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,9,9 and 3 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 92993-58:
(7*9)+(6*2)+(5*9)+(4*9)+(3*3)+(2*5)+(1*8)=183
183 % 10 = 3
So 92993-58-3 is a valid CAS Registry Number.
92993-58-3Relevant academic research and scientific papers
AZETIDINE DERIVATIVES FOR THE TREATMENT OF INTEGRIN ASSOCIATED DISEASES
-
Paragraph 77; 80, (2022/02/06)
The invention relates to novel compounds of formula (I), the compounds being capable of acting as avβ6 integrin antagonists, their use in the treatment of disease, their methods of manufacture and compositions comprising said compounds for such purposes (I) wherein R1 is selected from: R1a, -C(O)R1a, -C(O)OR1a -C(O)NHR1a, -C(O)N(R1a)2, -SO2R1a, wherein R1a are each independently selected from: alkyl, alkenyl, alkynyl, aryl, heteroaryl, alkylaryl or alkylheteroaryl, each of which may be optionally substituted; R2 is selected from: hydrogen, halogen, optionally substituted alkyl or optionally substituted alkoxyl; R2a are each independently selected from: hydrogen, halogen, optionally substituted alkyl or optionally substituted alkoxyl; R3 is selected from: hydrogen, optionally substituted alkyl or optionally substituted alkoxyl; R4 is hydroxyl; Ar1 is an optionally substituted heteroaryl or bicyclic heteroaryl; and L is a linker; or a pharmaceutically acceptable salt thereof.
Arylsulphonyl azetidine compounds, their preparation and their use as intermediates
-
, (2008/06/13)
Azetidine compounds of the general formula I STR1 wherein Ar represents a para-tolyl group and X represents a hydrogen atom, a carboxyl group or a hydroxymethyl group; their preparation from pentaerythritol via compounds of formula STR2 or two hydroxyl groups and Z represents Hal or OH, together with their use as intermediates in the preparation of 3-carboxyazetidine; also the compounds of formula STR3 wherein R1 and R2 both represent hydrogen, or together represent STR4 The compounds are intermediates for a known chemical hybridizing agent.
